Congenital central hypoventilation syndrome: Neurocognitive functioning in school age children
- 3 December 2009
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 45 (1) , 92-98
Abstract
Objective: Examine indices of neurocognitive functioning in children with PHOX2B mutation‐confirmed neonatal onset congenital central hypoventilation syndrome (CCHS) and relate them to indices of PHOX2B genotype, demographics, and disease severity.Methods: Subjects were 20 patients with PHOX2B mutation‐confirmed CCHS diagnosed as neonates who had undergone neurocognitive assessment in the course of clinical care at the Rush Children's Hospital CCHS Center between 1990 and 2006. Neurocognitive variables of interest included Full Scale IQ (FSIQ) and Wechsler‐derived marker indices (subtests) of verbal comprehension (Vocabulary), visuoperceptual reasoning (Block Design), working memory (Digit Span), and clerical/processing speed (Coding).Results: Single sample t‐tests revealed participants' general intelligence index (FSIQ; mean 84.9, SD 23.6) to be lower than the general population, though the range of FSIQ observed was broad. Visuoperceptual reasoning and clerical/visuographic speed marker indices were similarly depressed. These deficits were related to special education participation but not to PHOX2B genotype status or other demographic and clinical risk factors.Conclusions: PHOX2B mutation‐confirmed CCHS confers risk for adverse neurocognitive outcome, though the range of functioning observed raises questions about factors that may contribute to neurocognitive variability. Visuoperceptual reasoning and clerical/visuographic speed appear particularly vulnerable. PHOX2B genotype and disease severity indicators were unrelated to neurocognitive indices, possibly due to our modest sample. Future research should employ comprehensive neurocognitive assessment emphasizing visuoperceptual ability, mental speed, attention, and information processing efficiency. Increased recognition and expedited diagnosis with PHOX2B testing should allow larger studies of the relationship between neurocognitive functioning, PHOX2B genotype/mutation, and disease severity and management. Pediatr Pulmonol. 2010; 45:92–98.Keywords
Funding Information
- Chicago Community Foundation PHOX2B Patent Fund
This publication has 36 references indexed in Scilit:
- Familial dysautonomia: Frequent, prolonged and severe hypoxemia during wakefulness and sleepPediatric Pulmonology, 2008
- Congenital central hypoventilation syndrome: PHOX2B genotype determines risk for sudden deathPediatric Pulmonology, 2007
- The role of Phox2B in chromaffin cell developmentDevelopmental Biology, 2005
- PHOX2B gene mutation in a patient with late‐onset central hypoventilationPediatric Pulmonology, 2004
- Molecular analysis of congenital central hypoventilation syndromeHuman Genetics, 2003
- Cardiac rhythm disturbances among children with idiopathic congenital central hypoventilation syndromePediatric Pulmonology, 2000
- Respiratory sensations in subjects who lack a ventilatory response to CO2Respiration Physiology, 1993
- Neuropsychologic abnormalities in children with congenital central hypoventilation syndromeThe Journal of Pediatrics, 1992
- Congenital central hypoventilation syndrome: Diagnosis, management, and long-term outcome in thirty-two childrenThe Journal of Pediatrics, 1992
- Medical and psychosocial outcome of children with congenital central hypoventilation syndromeThe Journal of Pediatrics, 1991